Please enter your details to request more information

INVEST IN GAME CHANGING HEALTH CARE AI TECHNOLOGY

• 17.2X TARGET RETURNS

Predicting and diagnosing cancer and diabetes using AI

Investment Highlights

• HRMC EIS APPROVED – 30% Tax Relief
• Funded by an Innovate UK grant
• Supported by a UK Government Grant.
• Profits from the 42.2% CAGR forecast in the AI healthcare market by 2032.

We have built a world-class AI infrastructure designed to deliver never-before-seen levels of healthcare analytics and predictive oncology.

• Predictive Oncology – predicting disease outcomes including lung and breast cancer.
• Diabetes Care - The next level of monitorisation, management and treatment optimisation.
• Discovery & Biotech – Predicting drug target interactions.
• Access to the most extensive biological datasets.
• Unmatched medical research capabilities.
• Enables machine-to-machine AI Connectivity.

Next-generation medical care

To be able to deal with your enquiry effectively we will need to contact you via telephone and/or email. By enquiring you consent to being contacted and you consent to your data being stored in accordance with European GDPR regulations. Privacy Policy

Disclaimer: Any person accessing this website or page and considering potential investment opportunities featured here, should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This website or page should not be construed as advice or a personal recommendation to any prospective investor. Investments of this nature carry risks to your capital and can go up or down. Past performance is not indicative of future results. Suitable appropriately qualified investors, sophisticated and high net worth investors only.

*Based on company forecasts. See investment memorandum for more details